Literature DB >> 23065208

Significance of Tumor necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer.

Nega Berhane1, Rabinder Chandera Sobti, Shiferaw Melesse, Salih Abdul Mahdi, Afework Kassu.   

Abstract

Prostate cancer (PCa) is the most common noncutaneous cancer among men, accounting for 10 % of male cancer-related deaths worldwide. The etiology of PCa is largely unknown, although multiple environmental and lifestyle factors such as ultraviolet irradiation, smoking, and diet might increase the risk of the disease. Risk of disease varies most prominently with age, ethnicity, family history, and diet. The multifunctional cytokine tumor necrosis factor alpha (TNF-α) has an important role in the pathogenesis of inflammatory, autoimmune and malignant diseases. In this case control study 150 Prostate cancer patients and 150 age matched benign prostate hyperplasia (BPH) and equal number of healthy control groups were involved. The aim of this study was to analyze the effect of TNF-α-308 (G/A) polymorphism on risk of prostate cancer on north Indian prostate cancer patients. The polymerase chain reaction (PCR) technique was utilized to genotype TNF-α-308 (G/A) polymorphism. The present study showed statistically significant increased risk of prostate cancer among individuals that carried the A allele of TNF-α-308 gene (OR = 1.81, 95 % CI 1.00-3.481, p = 0.03).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065208     DOI: 10.1007/s11033-012-2020-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  Evaluation of the associations between the single nucleotide polymorphisms of the promoter region of the tumor necrosis factor-alpha gene and nasopharyngeal carcinoma.

Authors:  Sheng-Yow Ho; Ying-Jan Wang; Po-Chang Huang; Sen-Tien Tsai; Chih-Hung Chen; Helen H W Chen; Chih-Jen Chang; How-Ran Guo
Journal:  J Chin Med Assoc       Date:  2006-08       Impact factor: 2.743

2.  Prostate cancer pathology, screening, and epidemiology.

Authors:  E D Crawford; G J Miller; F Labrie; D Hirano; J Batuello; L M Glodé
Journal:  Rev Urol       Date:  2001

3.  Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis.

Authors:  Chao Shen; Haiming Sun; Donglin Sun; Lidan Xu; Xuelong Zhang; An Liu; Xueyuan Jia; Jing Bai; Feng Chen; Yang Yu; Yan Jin; Jingcui Yu; Songbin Fu
Journal:  Breast Cancer Res Treat       Date:  2010-09-30       Impact factor: 4.872

4.  Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection.

Authors:  S S Yea; Y I Yang; W H Jang; Y J Lee; H S Bae; K H Paik
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

5.  TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions.

Authors:  Maja Sirotkovic-Skerlev; Tamara Cacev; Simun Krizanac; Ana Kulić; Kresimir Pavelic; Sanja Kapitanovic
Journal:  Exp Mol Pathol       Date:  2007-01-17       Impact factor: 3.362

Review 6.  TNF and cancer: the two sides of the coin.

Authors:  Simone Mocellin; Donato Nitti
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer.

Authors:  G Mark Anderson; Marian T Nakada; Mark DeWitte
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

8.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.

Authors:  Pablo Sáenz-López; Rafael Carretero; José Manuel Cózar; José Maria Romero; Julia Canton; José Ramón Vilchez; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
Journal:  BMC Cancer       Date:  2008-12-19       Impact factor: 4.430

10.  Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.

Authors:  Iman A F Azmy; Saba P Balasubramanian; Anthony G Wilson; Timothy J Stephenson; Angela Cox; Nicola J Brown; Malcolm W R Reed
Journal:  Breast Cancer Res       Date:  2004-05-24       Impact factor: 6.466

View more
  6 in total

1.  Effect of cytotoxic T-lymphocyte antigen-4, TNF-alpha polymorphisms on osteosarcoma: evidences from a meta-analysis.

Authors:  Jianwei Liu; Junli Wang; Weiping Jiang; Yujin Tang
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

2.  A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis.

Authors:  Ya-Mei Tzeng; Li-Ting Kao; Herng-Ching Lin; Chao-Yuan Huang
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

3.  The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study.

Authors:  Dominique Z Jones; Camille Ragin; Nayla C Kidd; Rafael E Flores-Obando; Maria Jackson; Norma McFarlane-Anderson; Marshall Tulloch-Reid; Kevin S Kimbro; Lacreis R Kidd
Journal:  Hered Cancer Clin Pract       Date:  2013-12-23       Impact factor: 2.857

Review 4.  Association between tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis.

Authors:  Liping Ma; Jiangyang Zhao; Taijie Li; Yu He; Jian Wang; Li Xie; Xue Qin; Shan Li
Journal:  Diagn Pathol       Date:  2014-03-25       Impact factor: 2.644

5.  Tumor necrosis factor-alpha promoter polymorphism 308 G/A is not significantly associated with esophageal cancer risk: a meta-analysis.

Authors:  Ming Luo; Yuan Yang; Dongmei Luo; Liang Liu; Yuening Zhang; Feifan Xiao; Jingcheng Yang; Chengdong Zhang; Shen Fu; Zhiguo Luo
Journal:  Oncotarget       Date:  2016-11-29

6.  No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-α gene and susceptibility to prostate cancer: a comprehensive meta-analysis.

Authors:  Lei Yin; Chuang Yue; Hongwei Jing; Hongyuan Yu; Li Zuo; Tao Liu
Journal:  Hereditas       Date:  2020-04-07       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.